Seoul National University · Medicine
Professor Jae Seok Bae's research lab specializes in abdominal and liver imaging, with a focus on improving the diagnostic accuracy of medical imaging for hepatocellular carcinoma (HCC) and liver fibrosis. The lab investigates advanced imaging techniques such as contrast-enhanced ultrasound (CEUS), MRI with hepatobiliary agents (HBA-MRI), and elastography to enhance the detection and characterization of liver tumors, vascular invasion, and hepatic steatosis. A key research direction involves validating and optimizing the Liver Imaging Reporting and Data System (LI-RADS) criteria across different modalities, particularly in post-treatment and post-transplant settings. The lab also explores interventional radiology applications, including endoscopic balloon dilation and stent placement for gastrointestinal motility disorders.
Figures are computed from collected data and may differ slightly.
The sensitivity of MFI was higher than that of CDI or PDI in detecting the vascularity of HCCs when the vascular pattern was considered. MFI better detected the vascularity of shallow tumors.
For detecting HS ≥5%, MRI-PDFF was the best imaging modality, while ATI outperformed grayscale US. For detecting HS >33%, all five imaging tools demonstrated good diagnostic performance.
GA-MRI detected PVTT more often than CECT in HCC patients meeting the Milan criteria and better depicted PVTT in continuity with tumors and those showing enhancement than CECT.
Background The Liver Imaging Reporting and Data System (LI-RADS), version 2018, treatment response algorithm (TRA) is used to assess hepatocellular carcinoma (HCC) after local-regional therapy (LRT). However, its diagnostic performance has not yet been fully compared between CT and hepatobiliary agent (HBA)-enhanced MRI in patients who have undergone liver transplant (LT). Purpose To compare the diagnostic performance of LI-RADS TRA when using CT versus using HBA-enhanced MRI in an intraindividu
Background Diagnostic performance of the Liver Imaging Reporting and Data System tumor in vein (LR-TIV) category at CT and/or MRI has not yet been evaluated, to the knowledge of the authors. Purpose To assess the diagnostic performance of the LR-TIV category in detecting macroscopic tumors in veins (TIVs) at CT and hepatobiliary contrast agent-enhanced (HBA) MRI, with pathologic results used as the reference standard. Materials and Methods Between January 2010 and December 2019, consecutive pati
Balloon dilation is a safe and effective treatment for patients with pyloric spasms after PPG. In patients refractory to balloon dilations, retrievable stent placement can be a safe alternative tool.
Open papers in the app to read, cite, and organize with AI.
